Notice: Undefined offset: 0 in /usr2/unibs/application/modules/live-market/controllers/CompanyController.php on line 43
Glenmark Pharmaceuticals Share Price : Live NSE/BSE Stock Price Today
You are here » Home » Companies ยป Company Overview » Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd.

BSE: 532296 Sector: Health care
NSE: GLENMARK ISIN Code: INE935A01035
BSE 00:00 | 24 Apr 2020 Glenmark Pharmaceuticals Ltd is not traded on BSE in the last 30 days
NSE 05:30 | 01 Jan 1970 Glenmark Pharmaceuticals Ltd is not traded on NSE in the last 30 days

Notice: Undefined property: stdClass::$market_capital_for_nse in /usr2/unibs/application/modules/live-market/views/scripts/company/bs-new-bse-nse-block.php on line 17
OPEN 344.45
PREVIOUS CLOSE 340.15
VOLUME 715726
52-Week high 653.60
52-Week low 168.00
P/E 7.57
Mkt Cap.(Rs cr) 9,737
Buy Price 345.05
Buy Qty 6082.00
Sell Price 346.00
Sell Qty 186.00
OPEN 344.45
CLOSE 340.15
VOLUME 715726
52-Week high 653.60
52-Week low 168.00
P/E 7.57
Mkt Cap.(Rs cr) 9,737
Buy Price 345.05
Buy Qty 6082.00
Sell Price 346.00
Sell Qty 186.00

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd was incorporated in November 18th 1977. The company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The...> More

Glenmark Pharmaceuticals Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   9,737
EPS - TTM () [*S] 45.59
P/E Ratio (X) [*S] 7.57
Face Value ()   1
Latest Dividend (%)   200.00
Latest Dividend Date 19 Sep 2019
Dividend Yield (%) 0.58
Book Value / Share () [*S] 446.59
P/B Ratio () [*S] 0.77
[*C] Consolidated     [*S] Standalone    

Glenmark Pharmaceuticals Ltd - Financial Results

Particulars ( cr) Dec 2019 Dec 2018 % Chg
Net Sales 2735.56 2555.05 7.06
Other Income 32.96 -109.02 130.23
Total Income 2768.52 2446.03 13.18
Total Expenses 2295.49 2120.37 8.26
Operating Profit 473.04 325.67 45.25
Net Profit 190.84 116.34 64.04
Equity Capital 28.22 28.22 -
> More on Glenmark Pharmaceuticals Ltd Financials Results

Glenmark Pharmaceuticals Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Ajanta Pharma 1444.55 8.77 12603.70
Syngene Intl. 306.70 -2.12 12268.00
Natco Pharma 624.35 1.16 11366.29
Glenmark Pharma. 345.05 1.44 9737.31
Astrazeneca Phar 2777.50 7.33 6943.75
Proc. Gam. Heal. 4159.20 -0.05 6904.27
ERIS Lifescience 483.75 -0.05 6569.32
> More on Glenmark Pharmaceuticals Ltd Peer Group

Glenmark Pharmaceuticals Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 46.62
Banks/FIs 2.99
FIIs 28.51
Insurance 0.00
Mutual Funds 3.74
Indian Public 13.06
Custodians 0.00
Other 5.06
> More on Glenmark Pharmaceuticals Ltd Share Holding Pattern

Glenmark Pharmaceuticals Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week 9.77% 9.67% -0.83% -1.21%
1 Month 80.75% 80.93% 17.44% 17.35%
3 Month -1.64% -1.68% -24.72% -25.26%
6 Month 13.41% 13.34% -19.72% -20.96%
1 Year -45.69% -45.81% -19.79% -21.93%
3 Year -60.93% -60.89% 5.64% -0.69%

Glenmark Pharmaceuticals Ltd - STOCK STRENGTH

Today's Low/High 342.05
361.00
Week Low/High 304.70
361.00
Month Low/High 187.70
361.00
YEAR Low/High 168.00
654.00
All TIME Low/High 1.89
1262.00